Search research articles
Contact Us
Filters
Showing results (421-430 of 437) with videos related to
Page
of 44
Sort By:
European Journal of Epidemiology
|
June 1, 1997
Effect of maternal lifestyle on cord blood IgE factor
T Shirakawa, K Morimoto, S Sasaki, et al.
Cancer Research
|
February 2, 1999
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
T Ise, G Nagatani, T Imamura, et al.
International Journal of Sports Medicine
|
April 27, 2016
Effects of Cold Stimulation on Mitochondrial Activity and VEGF Expression in vitro
T Sugasawa, N Mukai, K Tamura, et al.
Journal of Cardiovascular Pharmacology
|
January 29, 2002
Neurally mediated syncope and cardiac beta-adrenergic receptor function
S Boh-Oka, H Ohmori, T Kawabe, et al.
Journal of Epidemiology
|
March 1, 2000
Randomized controlled trial of exercise training for older people (Sendai Silver Center Trial; SSCT): study design and primary outcome
I Tsuji, A Tamagawa, R Nagatomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 1, 1997
[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group]
H Akaza, N Miyanaga, T Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 5, 1999
Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria
N Miyanaga, H Akaza, T Tsukamoto, et al.
Anti-Cancer Drug Design
|
July 16, 1999
Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells
H Takano, T Ise, M Nomoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 1, 1997
[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group]
H Akaza, N Miyanaga, T Tsukamoto, et al.
Journal of Medical Genetics
|
April 3, 2004
Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy
H Ohmori, Y Ando, Y Makita, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 437) with videos related to
Sort By:
Page
of 44
European Journal of Epidemiology
|
June 1, 1997
Effect of maternal lifestyle on cord blood IgE factor
T Shirakawa, K Morimoto, S Sasaki, et al.
Cancer Research
|
February 2, 1999
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
T Ise, G Nagatani, T Imamura, et al.
International Journal of Sports Medicine
|
April 27, 2016
Effects of Cold Stimulation on Mitochondrial Activity and VEGF Expression in vitro
T Sugasawa, N Mukai, K Tamura, et al.
Journal of Cardiovascular Pharmacology
|
January 29, 2002
Neurally mediated syncope and cardiac beta-adrenergic receptor function
S Boh-Oka, H Ohmori, T Kawabe, et al.
Journal of Epidemiology
|
March 1, 2000
Randomized controlled trial of exercise training for older people (Sendai Silver Center Trial; SSCT): study design and primary outcome
I Tsuji, A Tamagawa, R Nagatomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 1, 1997
[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group]
H Akaza, N Miyanaga, T Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 5, 1999
Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria
N Miyanaga, H Akaza, T Tsukamoto, et al.
Anti-Cancer Drug Design
|
July 16, 1999
Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells
H Takano, T Ise, M Nomoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 1, 1997
[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group]
H Akaza, N Miyanaga, T Tsukamoto, et al.
Journal of Medical Genetics
|
April 3, 2004
Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy
H Ohmori, Y Ando, Y Makita, et al.
Page
of 44